Explaining Immunotherapy, PD-L1 and PD-1
Dr. Edward Garon explains the role of immunotherapy, PD-L1 and PD-1 in lung cancer. For more information visit www.lung.org/immunotherapy. Support for this educational program provided by Amgen, AstraZeneca, Blueprint Medicines, Bristol Myers Squibb, Genentech, Lilly Oncology, Merck, Novartis and Pfizer.
Suggested videos
Pursed Lip Breathing
American Lung Association · 2:27
Understanding Immunotherapy for NSCLC with PD-1 and PD-L1 Biomarkers
You and Lung Cancer · 4:27
Saved By The Scan :30 Matches PSA | American Lung Association
American Lung Association · 0:31
Cancer Immunotherapy - PD-1 and PD-L1
ImmunoOncology · 4:00
Belly Breathing
American Lung Association · 2:06
PD-L1/PD-1 Pathway: A Security Checkpoint
Genentech · 3:29
American Lung Association: Pulmonary Fibrosis
American Lung Association · 0:28
Dr. Brahmer Explains PD-1 and PD-L1
OncLive · 1:43
American Lung Association PSA, 1980
Chuck D's All-New Classic TV Clubhouse · 0:59
Are There Clinically Significant Distinctions Between PD-1 and PD-L1?
Global Resource for Advancing Cancer Education · 3:29
American Lung Association: What We Do
American Lung Association · 1:00
What is PD-1? Ask a Scientist
Cancer Research Institute · 2:01